Prophylaxis with a short course of OKT3 in renal transplantation: comparative analysis with recipients treated either with prophylactic ATG or with CyA.
Lloveras
J
J
Department of Nephrology, Hospital de l'Esperança, Barcelona, Spain.
Puig
J M
JM
Oliveras
A
A
Orfila
A
A
Comerma
I
I
Aubia
J
J
Masramón
J
J
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine